Quidel Corporation (QDEL)
(Delayed Data from NSDQ)
$119.51 USD
-2.81 (-2.30%)
Updated Apr 20, 2021 04:00 PM ET
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank | Definition | Annualized Return |
---|---|---|
1 | Strong Buy | 25.41% |
2 | Buy | 19.02% |
3 | Hold | 10.72% |
4 | Sell | 6.46% |
5 | Strong Sell | 3.06% |
S&P | 500 | 11.04% |
Zacks Rank Education - Learn about the Zacks Rank
Zacks Rank Home - Zacks Rank resources in one place
Zacks Premium - The only way to fully access the Zacks Rank
3-Hold of 5 3
The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.
Value Score | A |
---|---|
Growth Score | A |
Momentum Score | A |
VGM Score | A |
Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.
As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.
Zacks Style Scores Education - Learn more about the Zacks Style Scores
A Value A Growth B Momentum A VGM
The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
Zacks News
Quidel (QDEL) Stock Moves -0.28%: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed at $129.24 in the latest trading session, marking a -0.28% move from the prior day.
QDELNegative Net Change
daily-movers popular-stocks stocks-moving-today trending-companies trending-stocks trending-tickers
Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed the most recent trading day at $128.33, moving -1.47% from the previous trading session.
QDELNegative Net Change
daily-movers popular-stocks stocks-moving-today trending-companies trending-stocks trending-tickers
Quidel (QDEL) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed at $130.31 in the latest trading session, marking a +1.86% move from the prior day.
QDELNegative Net Change
daily-movers popular-stocks stocks-moving-today trending-companies trending-stocks trending-tickers
Quidel (QDEL) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Quidel (QDEL) closed at $126.30, marking a +0.13% move from the previous day.
QDELNegative Net Change
daily-movers popular-stocks stocks-moving-today trending-companies trending-stocks trending-tickers
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Delay in FDA approval for latest COVID test hasn't altered growth or value at 3X sales
VIVONegative Net Change HOLXNegative Net Change NVAXNegative Net Change QDELNegative Net Change
biotechs coronavirus medical
Quidel (QDEL) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed the most recent trading day at $138.90, moving -1.53% from the previous trading session.
QDELNegative Net Change
daily-movers popular-stocks stocks-moving-today trending-companies trending-stocks trending-tickers
Quidel (QDEL) Q4 Earnings Top Estimates
by Zacks Equity Research
Quidel (QDEL) delivered earnings and revenue surprises of 9.60% and -0.03%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
QDELNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Why Quidel Corp (QDEL) Might Surprise This Earnings Season
by Zacks Equity Research
Quidel Corp (QDEL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
QDELNegative Net Change
medical
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Small-cap diagnostics player will grow sales 30%+ to over $335 million on COVID-19 testing and its mutations
VIVONegative Net Change HOLXNegative Net Change QDELNegative Net Change
coronavirus medical
Quidel (QDEL) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed the most recent trading day at $236.38, moving +1.5% from the previous trading session.
QDELNegative Net Change
daily-movers popular-stocks stocks-moving-today trending-companies trending-stocks trending-tickers
Why Quidel (QDEL) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Quidel (QDEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
QDELNegative Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Quidel (QDEL) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Quidel (QDEL) is likely to have witnessed a recovery in rapid immunoassay revenues during Q4.
ECLPositive Net Change QDELNegative Net Change RDUSPositive Net Change OPCHNegative Net Change
medical
Quidel (QDEL) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed at $236.85 in the latest trading session, marking a +1.29% move from the prior day.
QDELNegative Net Change
daily-movers popular-stocks stocks-moving-today trending-companies trending-stocks trending-tickers
3 MedTech Stocks Likely to Top Estimates This Earnings Season
by Urmimala Biswas
Strong signs of rebound in base sales volumes make us optimistic about VIVO, XRAY, and PDCO's results.
BDXNegative Net Change XRAYNegative Net Change RMDPositive Net Change PDCONegative Net Change ABTNegative Net Change VIVONegative Net Change QDELNegative Net Change
medical
Quidel (QDEL) Stock Moves -0.87%: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed at $224.21 in the latest trading session, marking a -0.87% move from the prior day.
QDELNegative Net Change
daily-movers popular-stocks stocks-moving-today trending-companies trending-stocks trending-tickers
QIAGEN (QGEN) Announces COVID-19 Test Updates as Cases Rise
by Zacks Equity Research
QIAGEN (QGEN) along with with Australia-based digital diagnostics company, Ellume develops QIAreach SARS-CoV-2 Antigen Test.
HOLXNegative Net Change QGENNegative Net Change ABTNegative Net Change QDELNegative Net Change
medical
Top Ranked Growth Stocks to Buy for January 25th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 25th
QDELNegative Net Change MTHNegative Net Change APAMNegative Net Change FOCSNegative Net Change
consumer-staples finance medical
Boston Scientific (BSX) Enhances Core Business With Buyout
by Zacks Equity Research
Boston Scientific's (BSX) acquisition of Preventice solutions enables the former to expand rhythm management diagnostics portfolio and abilities.
VIVONegative Net Change BSXPositive Net Change QDELNegative Net Change AHCOPositive Net Change
medical
Integra (IART) Acquires Acell, Focuses on Regenerative Space
by Zacks Equity Research
The acquisition is expected to remain accretive to Integra's (IART) revenue growth and adjusted gross margins.
IARTNegative Net Change VIVONegative Net Change QDELNegative Net Change AHCOPositive Net Change
medical
The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Becton, Dickinson and Co, Quidel and Hologic
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Quest Diagnostics, Abbott, Becton, Dickinson and Co, Quidel and Hologic
BDXNegative Net Change DGXNegative Net Change HOLXNegative Net Change ABTNegative Net Change QDELNegative Net Change
medical
Globus Medical (GMED) US Spine Grows, Pricing Pressure Stays
by Zacks Equity Research
Globus Medical's (GMED) recent product launches are seeing tremendous uptake.
VIVONegative Net Change QDELNegative Net Change GMEDPositive Net Change AHCOPositive Net Change
medical
Federal, Private Tie-Ups Boost COVID-19 Testing Volume
by Urmimala Biswas
The Department of Health and Human Services (HHS) promises over $22 billion of funding.
BDXNegative Net Change DGXNegative Net Change HOLXNegative Net Change ABTNegative Net Change QDELNegative Net Change
medical
Insulet (PODD) Omnipod DASH Reaches Canada, Global Hold Widens
by Zacks Equity Research
Insulet's (PODD) Omnipod DASH system provides 72 hours of continuous insulin therapy, simplifying lives with no more daily injection.
VIVONegative Net Change QDELNegative Net Change PODDPositive Net Change AHCOPositive Net Change
medical
PerkinElmer (PKI) Receives FDA EUA for Asymptomatic Testing
by Zacks Equity Research
PerkinElmer's (PKI) RT-PCR assay to test individuals without COVID-19 symptoms acts as prime factor in controlling the spread.
PKINegative Net Change VIVONegative Net Change QDELNegative Net Change AHCOPositive Net Change
medical
4 Momentum Stocks to Explore the Lucrative Driehaus Strategy
by Nitish Marwah
Investors who have the propensity to take a higher risk can think of investing in momentum stocks to boost their gains.
BIDUNegative Net Change QDELNegative Net Change HLFPositive Net Change CROXNegative Net Change
internet medical retail